|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2022
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/21183
Title: | Assessment of quality of life in COPD patients with comorbidities |
Authors: | Stavila, Ecaterina |
Issue Date: | 2022 |
Publisher: | Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova, Association of Medical Students and Residents |
Citation: | STAVILA, Ecaterina. Assessment of quality of life in COPD patients with comorbidities. In: MedEspera: the 9th International Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2022, p.154. |
Abstract: | Introduction. Chronic obstructive pulmonary disease (COPD) continues to be one of the leading causes of
death and health-care cost worldwide. The majority of patients have at least one comorbid condition of
clinical significance.
Aim of study. Study of comorbidities in chronic obstructive pulmonary diseases.
Methods and materials. The study was conducted in 75 patients with COPD. Comorbidities were assessed
by Charlson comorbidity index (CCI). Health-related quality of life was assessed by the Clinical COPD
Questionnaire (CCQ), COPD Assessment Test (CAT) and St. George Respiratory Questionnaire (SGRQ).
Spirometric data were analyzed (FEV1, FVC, FEV1/FVC).
Results. 75 COPD patients were studied, mean age was 59.2±6.5 years, mean FEV1, % was 36.6±13.3%.
Patients across all stages of the GOLD classification had similar age and pack/years (p>0.01). Charlson
comorbidity index (CCI) had a moderate negative correlation with 6MWD (r=-0.39, p<0.01) and absence
correlation with the rate of exacerbations (r=0.15, p=0.01). CCI had a moderate correlation with SGRQ
activity (r=0.39, p<0.01), impact (r=0.38, p<0.001) and total (r=0.38, p<0.001) scores. Questionnaires for
assessing the quality of life when applied to assess the risk of comorbidities showed unsatisfactory
discriminatory power (SGRQ AUC - 0.4, CCQ AUC - 0.44 and CAT AUC - 0.39).
Conclusion. COPD is frequently associated with other diseases. Comorbidities have a greater negative
impact on COPD patients in terms of quality of life. HRQL questionnaires, when applied to assess the risk
of comorbidities showed unsatisfactory discriminatory power. |
metadata.dc.relation.ispartof: | MedEspera: The 9th International Medical Congress for Students and Young Doctors, May 12-14, 2022, Chisinau, Republic of Moldova |
URI: | https://medespera.asr.md/en/books?page=1 http://repository.usmf.md/handle/20.500.12710/21183 |
Appears in Collections: | MedEspera 2022
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|